We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002459:SZSEJA Solar Technology Co., Ltd. Analysis

Data as of 2026-06-14 - not real-time

CN¥8.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

JA Solar is trading at CNY 8.85, still below its 20‑day SMA of 9.19 and well under the 50‑day (10.20) and 200‑day (11.91) averages, indicating a bearish price momentum. The RSI sits at 39.8, suggesting the stock is approaching oversold territory, while the MACD shows a bullish signal despite a negative line, hinting at a possible short‑term rebound. Volume is increasing, but the 30‑day volatility is high at 44.5 % and beta is low (0.20), reflecting a stock that moves sharply yet is less correlated with the broader market. Fundamental metrics are weak: revenue fell 13.6 %, gross margin is negative, operating margin is –8.6 %, and debt‑to‑equity is a staggering 240, underscoring financial strain. Cash reserves exceed CNY 23 bn, yet free cash flow remains deeply negative, and the DCF‑derived fair value of 1.86 is far below the current price, implying an overvaluation gap despite a model‑generated upside of about 31 %. The sector faces medium regulatory risk as Chinese solar subsidies evolve, and the company’s global exposure adds a medium geographic risk profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • RSI near oversold but momentum still bearish
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential earnings recovery indicated by forward EPS
  • Continued financial strain from high debt and negative cash flow
  • Sector secular growth offset by regulatory uncertainty

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Fundamental deficits (negative margins, massive debt)
  • DCF fair value far below market price
  • Long‑term exposure to policy‑driven solar market cycles

Key Metrics & Analysis

Financial Health

Revenue Growth-13.60%
Profit Margin-8.47%
P/E Ratio33.6
ROE-16.97%
ROA-2.38%
Debt/Equity240.24
P/B Ratio1.3
Op. Cash FlowCN¥3.7B
Free Cash FlowCN¥-10588769280
Industry P/E36.8

Technical Analysis

TrendBearish
RSI39.8
SupportCN¥7.92
ResistanceCN¥10.40
MA 20CN¥9.19
MA 50CN¥10.20
MA 200CN¥11.91
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥1.86
Target PriceCN¥11.62
Upside/Downside31.27%
GradeOvervalued
TypeValue

Risk Assessment

Beta0.20
Volatility44.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.